Nasari, Appal I.
HRN: 21-40-10 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2022
CEFUROXIME 1.5GM (VIAL)
05/21/2022
05/28/2022
IV
1.5g
Q8h
Indirect Hernia
Waiting Final Action